Ansornitinib
Product Specifications
UNSPSC Description
Ansornitinib is an orally active dual kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2). Ansornitinib can be used as an antifibrotic agent in lung, liver, kidney, and gastrointestinal fibrotic diseases[1].
Target Antigen
PDGFR; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ansornitinib.html
Solubility
DMSO : 40 mg/mL (ultrasonic;warming;adjust pH to 2 with 1M HCl;heat to 80°C)
Smiles
CN(CC1)CCN1CC(N(C)C(C=C2)=CC=C2N/C(C3=CC=CC=C3)=C4C5=CC=C(C(OC)=O)N=C5NC/4=O)=O
Molecular Weight
540.61
References & Citations
[1]Shakil ASLAM, et al. Reducing fibrosis and treating related diseases, disorders, and conditions. WO2022006278
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147243/Ansornitinib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147243/Ansornitinib-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1448874-96-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1390102-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C3H1.14 (SPAC3H1.14, SPAC9G1.01)
Ask
View Details MBS1390102-02 0.1 mg (E-Coli)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C3H1.14 (SPAC3H1.14, SPAC9G1.01)
Ask
View Details